Bone grafting is replacement of damaged part of dental structure with the help of grafts such as autografts, allograft or xenograft. Patients with teeth missing need to undergo a dental implant procedure, however, if their jaw bone is thin or soft and is not able to hold the dental implant in its place, then they need to undergo a bone graft procedure. Synthetic substitutes such as Hydroxyapatite (HA) and Tricalcium Phosphate (TCP) are also been used in dental procedures. Various factors for dental deformities include gum disease, traumas, injuries, accidents, and genetic defects. Bone grafts offer various advantages such as preserving the structure and strength of the jaw bone, avoids the possibility of narrow and fragile jaw bone.
Get Exclusive Sample Report at: https://www.coherentmarketinsights.com/insight/request-sample/1187
Bone graft materials are available in varieties such as allografts, xenografts, and synthetic substitutes and can be custom made according to the need of the patient, which makes it convenient for both, the physician and patient driving the growth of the market. Bone grafts are widely available from various sources such as from patients, from another donor, from animal sources, or are synthetically made. Furthermore, advancements in technology has led to development of synthetic graft options with better stability, sterility, and long life. These advancements have reduced surgical times along with post-operative pain and have improved healing time increasing adoption of these substitutes which has impacted the market. Development of biocompatible bone grafts such as B-OstiN and hydroxyapatite allografts and advent of different variants is a factor expected to fuel growth of the global dental bone graft substitutes market over the forecast period.
Increasing medical tourism is expected to aid in growth of the global dental bone graft and substitutes market over the forecast period
Advancements in bone graft substitutes has provided better alternative to bone grafts for patients, however, high cost has limited its adoption among price sensitive customers. Developed regions such as North America and Europe have presence of innovative product manufacturers in this product space. However, the costs of the products as well as the procedural costs for in the hospitals in these regions are comparatively higher than that in the emerging economies such as India, China, and Brazil which may prove to be primary driving factor for growth in this market. According to OrthoStreams, orthopedic surgeries in China and other emerging economies is 75% cheaper as compared to that of the procedures performed in the U.S. Hospitals in emerging economies have access to advanced technologies and skilled surgeons to perform the procedure with same level of precision as that in developed countries. Costs associated with any surgical procedures are lower in emerging economies such as India as overall cheaper costs for everything associated with such procedures depending on complexity of the surgeries. Furthermore, hospitals use locally manufactured graft and graft substitutes for bone grafting procedures that provide equivalent levels of performance to that of the globally available commercial bone graft substitutes. According to International Journal of Pharmaceutical Sciences Review and Research, 2015, dental surgeries cost three to four times more in developed regions than in India. Thus, a large patient pool migrates to India so as to avail bone grafting procedures, leading to growth of the dental bone graft and substitutes market in Asia Pacific.
Buy Now This Report: https://www.coherentmarketinsights.com/insight/buy-now/1187
Some major players operating in the dental bone graft and substitutes market are Institut Straumann AG, Geistlich, DENTSPLY International, Zimmer Biomet, Medtronic Plc., BioHorizons IPH, Inc., ACE Surgical Supply Company, Inc., RTI Surgical, Inc., LifeNet Health, and Citagenix